{ 135件 }
Sho Furusawa, Hiroshi Nomoto, Chiho Oba-Yamamoto, Jun Takeuchi, Miki Ito, Hiroyoshi Kurihara, Shin Aoki, Aika Miya, Hiraku Kameda, Akinobu Nakamura, and Tatsuya Atsumi Real-world clinical evidence of oral semaglutide on metabolic abnormalities in subjects with type 2 diabetes: a multicenter retrospective observational study (the Sapporo-Oral SEMA study) ENDOCRINE JOURNAL, in press
IF: 2.0
Aika Miya, Akinobu Nakamura, Yuka Suzuki, Hiroshi Nomoto, Hiraku Kameda, Kyu Yong Cho, Tatsuya Atsumi Frequency and Determinants of Lipid Management Target Achievement in Primary Prevention of Cardiovascular Disease in Type 2 Diabetes Diabetology International, in press.
IF: 2.2
日本糖尿病・肥満動物学会 研究賞 中村 昭伸先生
Aika Miya, Akinobu Nakamura, Hiroshi Nomoto, Hiraku Kameda, Tatsuya Atsumi Positive association between the proinsulin-to-C-peptide ratio and prolonged hyperglycemic time in type 2 diabetes Endocrine Journal, in press.
IF=2.0
Iesaka H, Kameda H, Miya A, Nomoto H, Cho KY, Nakamura A, Abe T, Shinohara N, Atsumi T Fulminant ACTH decrease following diabetic ketoacidosis induced by immune checkpoint inhibitor combination therapy with nivolumab and
ipilimumab: A case report
Medicine, in press
IF: 1.6
Izumihara R, Nomoto H*, Kito K, Yamauchi Y, Omori K, Shibayama Y, Yanagiya S, Miya A, Kameda H, Cho KY, Nagai S, Sakuma I, Nakamura A, Atsumi T.
Switching from conventional fibrates to pemafibrate has beneficial effects on the renal function of diabetic subjects with chronic kidney disease.
Diabetes Metab J, in press.
IF: 5.9, 5-Y IF: 5.4
Sho Furusawa, Hiroshi Nomoto, Hiroki Yokoyama, Yuka Suzuki, Atsushi Tsuzuki, Kiyohiko Takahashi, Aika Miya, Hiraku Kameda, Kyu Yong Cho, Jun Takeuchi, So Nagai, Shinji Taneda, Yoshio Kurihara, Akinobu Nakamura, Tatsuya Atsumi.
Glycemic control efficacy of switching from dipeptidyl peptidase-4 inhibitors to oral semaglutide in subjects with type 2 diabetes: a multicenter, prospective, randomized, open-label, parallel-group comparison study (SWITCH-SEMA 2 study) Diabetes, Obesity and Metabolism, in press
IF=5.8
Akinobu Nakamura, Aika Miya, Yuka Suzuki, Hiroshi Nomoto, Hiraku Kameda, Kyu Yong Cho, So Nagai, Tatsuya Atsumi.
Positive association between proinsulin and fatty liver index in people with type 2 diabetes.
Endocr J, in press.
IF: 2.0
Nomoto H, Kito K, Iesaka H, Handa T, Yanagiya S, Miya A, Kameda H, Cho KY, Takeuchi J, Nagai S, Sakuma I, Nakamura A, Atsumi T.
Preferable Effects Of Pemafibrate On Liver Function And Fibrosis In Subjects With Type 2 Diabetes Complicated With Liver Damage Diabetol Metab Syndr, in press IF= 4.7
Sekizaki T, Kameda H, Nakamura A, Kuwabara S, Nomoto H, Cho KY, Ishi Y, Motegi H, Miyoshi H, Atsumi T.
Neuromedin B receptor as a potential therapeutic target for corticotroph adenomas Pituitary, in press IF = 3.8